News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Drug Development
Acambis PLC Release: Research Update
September 12, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Cambridge, UK -- (MARKET WIRE) -- September 12, 2006 -- Acambis announces encouraging data from Phase 2 trial of West Nile virus vaccine
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase II
Europe
MORE ON THIS TOPIC
Layoffs
After Safety Stumbles, Keros Axes Pulmonary Hypertension Drug, 45% of Staff
May 30, 2025
·
2 min read
·
Tristan Manalac
Gene therapy
Analysts Brush Off Intellia’s Adverse Event but Gene Therapy Safety Concerns Continue
May 29, 2025
·
3 min read
·
Annalee Armstrong
Lung cancer
Merck, Daiichi Sankyo Pull Lung Cancer Filing for ADC, Citing Underwhelming Survival Findings
May 29, 2025
·
2 min read
·
Tristan Manalac
Infectious disease
Moderna Loses $760M+ Government Bird Flu Contract as Vaccine Uncertainties Mount
May 29, 2025
·
2 min read
·
Tristan Manalac
